Edges in Network
Network | GSE18864_egf1520 - GSE18864 - SiGN-BN HC+Bootstrap |
Network Description | Tumor expression data from neoadjuvant trial of cisplatin monotherapy in triple negative breast cancer patients |
Node | RPL26L1 |
Upstream (Parents) |
---|
(<<) ACTN1 → RPL26L1 |
(<<) CASKIN1 → RPL26L1 |
(<<) CAV1 → RPL26L1 |
(<<) EP300 → RPL26L1 |
(<<) KRTAP1-3 → RPL26L1 |
(<<) MAPK1 → RPL26L1 |
(<<) MVK → RPL26L1 |
(<<) MYLK → RPL26L1 |
(<<) PTGER1 → RPL26L1 |
(<<) RAC1 → RPL26L1 |
(<<) ROCK2 → RPL26L1 |
(<<) RPL35 → RPL26L1 |
(<<) TAF9 → RPL26L1 |
Downstream (Children) |
---|
RPL26L1 → ATP2B4 (>>) |
RPL26L1 → CBL (>>) |
RPL26L1 → DOCK9 (>>) |
RPL26L1 → EML4 (>>) |
RPL26L1 → GNAL (>>) |
RPL26L1 → GPR78 (>>) |
RPL26L1 → GRHPR (>>) |
RPL26L1 → MAN2A2 (>>) |
RPL26L1 → MAP3K5 (>>) |
RPL26L1 → MYL6B (>>) |
RPL26L1 → NUPR1 (>>) |
RPL26L1 → PDRG1 (>>) |
RPL26L1 → PFDN1 (>>) |
RPL26L1 → PLD1 (>>) |
RPL26L1 → PRKCI (>>) |
RPL26L1 → PRPF4B (>>) |
RPL26L1 → PTMA (>>) |
RPL26L1 → RBKS (>>) |
RPL26L1 → ROR2 (>>) |
RPL26L1 → RPL36 (>>) |
RPL26L1 → SHB (>>) |
RPL26L1 → TIMM13 (>>) |
RPL26L1 → UBE2D2 (>>) |
RPL26L1 → UBE2N (>>) |